Exploring CLL, ‘A Manageable Cancer for a Lot of Patients’

There have been major treatment advancements for CLL in the last decade, with future generations of drugs on the horizon.

One expert explains why most of the time clinical trial enrollment is ‘the correct answer’ for patients.

From social work to cardio-oncology, there is a wide array of resources potentially available to patients, as one expert explained.

One expert explained why chronic lymphocytic leukemia is erroneously considered a ‘good cancer.’